about
The coming age of data-driven medicine: translational bioinformatics' next frontierUnsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' viewsACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingAdvising patients about obtaining genomic profiles.Self-guided management of exome and whole-genome sequencing results: changing the results return model.Genetics patients' perspectives on clinical genomic testing.Molecular genetic testing and the future of clinical genomics.Translational bioinformatics embraces big data.Fruit flies in biomedical research.You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative.A genome sequencing program for novel undiagnosed diseases.Patients' perceived utility of whole-genome sequencing for their healthcare: findings from the MedSeq project.Incidentalome from Genomic Sequencing: A Barrier to Personalized Medicine?The emerging role for rat models in gene discovery.Clinical care models in the era of next-generation sequencing.Exploring concordance and discordance for return of incidental findings from clinical sequencing.Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.Next-generation sequencing in the clinic: are we ready?My46: a Web-based tool for self-guided management of genomic test results in research and clinical settingsTo tell or not to tell? A systematic review of ethical reflections on incidental findings arising in genetics contexts.Incidental findings from clinical genome-wide sequencing: a review.Interactive e-counselling for genetics pre-test decisions: where are we now?Defining and managing incidental findings in genetic and genomic practice.The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.Return of genetic testing results in the era of whole-genome sequencing.Descriptive epidemiology of birth defects thought to arise by new mutation.A personal perspective on returning secondary results of clinical genome sequencing.Ethical considerations associated with clinical use of next-generation sequencing in children.Secondary variants--in defense of a more fitting term in the incidental findings debate.Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.The advent of personal genome sequencing.Developing standards for chromosomal microarray testing counselling in paediatrics.Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis.Is There a Right Time to Know? The Right Not to Know and Genetic Testing in Children.Whole-genome sequencing and the physician.Pediatric research and the return of individual research results.Enhancing exposure to genetics and genomics through an innovative medical school curriculum.Experiences with obtaining informed consent for genomic sequencing.Whole genome sequencing: a considered approach to clinical implementationGenetics professionals' perspectives on reporting incidental findings from clinical genome-wide sequencing
P2860
Q28386235-C43C607A-9A76-4679-AD9C-446C5304E90EQ28597904-715DC527-9001-4B3A-8D44-6632B9E4618DQ29616235-22A273D0-551C-4E55-AC67-AD618EF1DA15Q30419716-3D264F27-7112-4442-B195-39BF969ED34CQ33566296-51098CED-5183-419E-BD7B-4FE639F9491EQ33771605-DE0A34DD-C003-4F40-AAE6-0C30C47B6F39Q34345162-614E2575-43A2-4513-84EF-090E755D1350Q34378848-E11C22D9-CE26-4437-972E-1EFC518FF2B7Q35145708-45D19052-DDA2-4CA4-8729-8B56C524CD51Q35627358-9F8CFCDC-C4BB-4E41-945E-81A23480B96FQ36074256-858DE6D3-7ABB-4721-83E8-978FC7483BD2Q36724985-57F5962A-23E5-4FCB-89DE-1D8F2832E59EQ36754075-E6CDB11F-9845-41A1-97EA-4273B28C9F13Q36814740-F56418CE-1CD1-4BD2-AD35-125EDB0215A8Q36902963-5FB4F736-A99B-49ED-91BD-4E2B2E1BF576Q37148894-8BDFC1A5-BFC7-4F84-AF5D-DC18C75CC0D3Q37463409-84992F1C-ABF5-4D77-8620-AB740434CFA9Q37478694-B0F9445D-954A-4DA0-B4D9-EAAA8B66F737Q37702883-75B60CE1-BBB1-466B-92FC-A72067E2797BQ38022136-3FE25614-A237-4FB3-BFF0-3EFE941671EBQ38109552-7DD2C48D-FD91-43B0-B7BB-E493FB702345Q38211768-ECFC0AD2-70E0-4E54-A31A-DB9818989EAFQ38250263-DDD6339C-1CCF-48EB-A596-6CC1787C3386Q38392363-74C6B558-5072-4390-9157-5D0416C6F9E8Q38560292-47B156BA-402D-4AE2-A5BD-97021699C2C9Q40675272-2C292307-0486-4B42-9DBA-562257DFE832Q41361200-70BADE1C-5B5A-4F56-93C4-EE3631D02615Q42150831-E37DD48D-58CF-4B0D-9814-2BF0CEF1A957Q43555478-AD0C6D5C-CD04-4B24-8504-7F56CB4A9239Q43590500-30BCEE8A-3964-49EA-B333-AAEE4F30E2DDQ43669448-615672EF-C4BF-4174-A5AE-3E3A0B68CE5AQ47669985-307B6637-D76B-49A0-A394-B0A31921AC9BQ47770082-A0E2EBAF-5EAE-4A69-81C4-2B15E7BF1227Q48084790-40C69EDB-D31B-4959-85BF-BBE2602D62EFQ48470406-28077D8C-8B6E-46EB-B094-F26A1BA00DC4Q48545491-619C1FC5-43A8-44C1-93B5-37B509817367Q50976587-4C8BEDCC-AE69-4F45-88EA-F88E4F64989DQ54858926-4768823D-0C5C-4078-9602-AEE100208C3AQ56773312-F6E31D3C-E590-46FD-AF1F-DF36D9C9F6C5Q57386641-73B8F30B-9D25-4418-8ED8-0BE111B87C2B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A timely arrival for genomic medicine.
@ast
A timely arrival for genomic medicine.
@en
A timely arrival for genomic medicine.
@nl
type
label
A timely arrival for genomic medicine.
@ast
A timely arrival for genomic medicine.
@en
A timely arrival for genomic medicine.
@nl
prefLabel
A timely arrival for genomic medicine.
@ast
A timely arrival for genomic medicine.
@en
A timely arrival for genomic medicine.
@nl
P2093
P1433
P1476
A timely arrival for genomic medicine.
@en
P2093
Alan N Mayer
David A Margolis
David P Bick
Elizabeth A Worthey
Howard J Jacob
James W Verbsky
Marjorie J Arca
P2860
P2888
P304
P356
10.1097/GIM.0B013E3182095089
P407
P577
2011-03-01T00:00:00Z
P5875
P6179
1032874172